본문 바로가기
KERD
논문KCI 등재

유전성 폐동맥고혈압과 관련된 유전자 연구

Genetics in heritable pulmonary arterial hypertension

2

조회

0

다운로드

1

인용

0

참고문헌

키워드

주제분류내과학

초록

Pulmonary arterial hypertension is caused by vascular remodeling including muscularization of arteries, loss of small precapillary arteries, and formation of neointima and plexiform lesion, resulting in a progressive increase in pulmonary vascular resistance. About 70% of heritable pulmonary arterial hypertension and 10% to 40% of idiopathic pulmonary arterial hypertension patients possess mutations in bone morphogenetic protein receptor, type 2 (BMPR2), which is a type II receptor of TGF-β superfamily. Very rarely, mutations in another receptors of TGF-β superfamily, activin-like kinase-type 1 (ALK1) and endoglin (ENG) are found in pulmonary arterial hypertension patients with hereditary hemorrhagic telangiectasia. Genetic screening is useful to identify family members who are mutation carriers in heritable pulmonary arterial hypertension families.

Abstract

Pulmonary arterial hypertension is caused by vascular remodeling including muscularization of arteries, loss of small precapillary arteries, and formation of neointima and plexiform lesion, resulting in a progressive increase in pulmonary vascular resistance. About 70% of heritable pulmonary arterial hypertension and 10% to 40% of idiopathic pulmonary arterial hypertension patients possess mutations in bone morphogenetic protein receptor, type 2 (BMPR2), which is a type II receptor of TGF-β superfamily. Very rarely, mutations in another receptors of TGF-β superfamily, activin-like kinase-type 1 (ALK1) and endoglin (ENG) are found in pulmonary arterial hypertension patients with hereditary hemorrhagic telangiectasia. Genetic screening is useful to identify family members who are mutation carriers in heritable pulmonary arterial hypertension families.

참고문헌 (50)

  1. Gaine SP, "Primary pulmonary hypertension", Lancet, 352, pp.719~725 (1998)
  2. Humbert M, "Pulmonary arterial hypertension in France: results from a national registry", Am J Respir Crit Care Med, 173, pp.1023~1030 (2006)
  3. Simonneau G, "Updated clinical classification of pulmonary hypertension", J Am Coll Cardiol, 54, pp.S43~54 (2009)
  4. Rabinovitch M, "Molecular pathogenesis of pulmonary arterial hypertension", J Clin Invest, 118, pp.2372~2379 (2008)
  5. Deng Z, "Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene", Am J Hum Genet, 67, pp.737~744 (2000)
  6. International PPH Consortium, "Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension", Nat Genet, 26, pp.81~84 (2000)
  7. Newman JH, "Mutation in the gene for bone morphogenetic protein receptor II as a cause of primary pulmonary hypertension in a large kindred", N Engl J Med, 345, pp.319~324 (2001)
  8. Trembath RC, "Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia", N Engl J Med, 345, pp.325~334 (2001)
  9. Chaouat A, "Endoglin germline mutation in a patient with hereditary haemorrhagic telangiectasia and dexfenfluramine associated pulmonary arterial hypertension", Thorax, 59, pp.446~448 (2004)
  10. Rich S, "Primary pulmonary hypertension. A national prospective study", Ann Intern Med, 107, pp.216~223 (1987)
  11. Machado RD, "Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension", Hum Mutat, 27, pp.121~132 (2006)
  12. Cogan JD, "Gross BMPR2 gene rearrangements constitute a new cause for primary pulmonary hypertension", Genet Med, 7, pp.169~174 (2005)
  13. Aldred MA, "BMPR2 gene rearrangements account for a significant proportion of mutations in familial and idiopathic pulmonary arterial hypertension", Hum Mutat, 27, pp.212~213 (2006)
  14. Thomson JR, "Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta family", J Med Genet, 37, pp.741~745 (2000)
  15. Souza R, "Pulmonary arterial hypertension associated with fenfluramine exposure: report of 109 cases", Eur Respir J, 31, pp.343~348 (2008)
  16. Aldred MA, "haracterization of the BMPR2 5'-untranslated region and a novel mutation in pulmonary hypertension", Am J Respir Crit Care Med, 176, pp.819~824 (2007)
  17. Machado RD, "Genetic association of the serotonin transporter in pulmonary arterial hypertension", Am J Respir Crit Care Med, 173, pp.793~797 (2006)
  18. Machado RD, "Genetics and genomics of pulmonary arterial hypertension", J Am Coll Cardiol, 54, pp.S32~42 (2009)
  19. Chang H, "Genetic analysis of the mammalian transforming growth factor-beta superfamily", Endocr Rev, 23, pp.787~823 (2002)
  20. Goumans MJ, "Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta", ALK5 signaling, 2003, pp.12, 817~828
  21. Rahimi RA, "TGF-beta signaling: a tale of two responses", J Cell Biochem, 102, pp.593~608 (2007)
  22. Hassel S, "Proteins associated with type II bone morphogenetic protein receptor (BMPR-II) and identified by two-dimensional gel electrophoresis and mass spectrometry", Proteomics, 4, pp.1346~1358 (2004)
  23. Yang X, "Dysfunctional Smad signaling contributes to abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension", Circ Res, 96, pp.1053~1063 (2005)
  24. Machado RD, "Functional interaction between BMPR-II and Tctex-1, a light chain of Dynein, is isoform- specific and disrupted by mutations underlying primary pulmonary hypertension", Hum Mol Genet, 12, pp.3277~3286 (2003)
  25. Rudarakanchana N, "Functional analysis of bone morphogenetic protein type II receptor mutations underlying primary pulmonary hypertension", Hum Mol Genet, 11, pp.1517~1525 (2002)
  26. Harrison RE, "Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia", J Med Genet, 40, pp.865~871 (2003)
  27. Mache CJ, "Early-life pulmonary arterial hypertension with subsequent development of diffuse pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia type 1", Thorax, 63, pp.85~86 (2008)
  28. Harrison RE, "Transforming growth factor-beta receptor mutations and pulmonary arterial hypertension in childhood", Circulation, 111, pp.435~441 (2005)
  29. Fujiwara M, "Implications of mutations of activin receptor-like kinase 1 gene (ALK1) in addition to bone morphogenetic protein receptor II gene (BMPR2) in children with pulmonary arterial hypertension", Circ J, 72, pp.127~133 (2008)
  30. Gallione CJ, "A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4)", Lancet, 363, pp.852~859 (2004)
  31. Gallione CJ, "SMAD4 mutations found in unselected HHT patients", J Med Genet, 43, pp.793~797 (2006)
  32. Upton PD, "TGF-beta and BMPR-II pharmacology-- implications for pulmonary vascular diseases", Curr Opin Pharmacol, 9, pp.274~280 (2009)
  33. David L, "Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells", Blood, 109, pp.1953~1961 (2007)
  34. Teichert-Kuliszewska K, "Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension", Circ Res, 98, pp.209~217 (2006)
  35. Atkinson C, "Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor", Circulation, 105, pp.1672~1678 (2002)
  36. Morrell NW, "Cellular and molecular basis of pulmonary arterial hypertension", J Am Coll Cardiol, 54, pp.S20~31 (2009)
  37. Hagen M, "Interaction of interleukin-6 and the BMP pathway in pulmonary smooth muscle", Am J Physiol Lung Cell Mol Physiol, 292, pp.L1473~1479 (2007)
  38. Beppu H, "BMP type II receptor is required for gastrulation and early development of mouse embryos", Dev Biol, 221, pp.249~258 (2000)
  39. Long L, "Serotonin increases susceptibility to pulmonary hypertension in BMPR2-deficient mice", Circ Res, 98, pp.818~827 (2006)
  40. Song Y, "Increased susceptibility to pulmonary hypertension in heterozygous BMPR2-mutant mice", Circulation, 112, pp.553~562 (2005)
  41. Hong KH, "Genetic ablation of the BMPR2 gene in pulmonary endothelium is sufficient to predispose to pulmonary arterial hypertension", Circulation, 118, pp.722~730 (2008)
  42. Remillard CV, "Function of Kv1.5 channels and genetic variations of KCNA5 in patients with idiopathic pulmonary arterial hypertension", Am J Physiol Cell Physiol, 292, pp.C1837~1853 (2007)
  43. Eddahibi S, "Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension", J Clin Invest, 108, pp.1141~1150 (2001)
  44. Koehler R, "Serotonin transporter gene polymorphism in a cohort of German patients with idiopathic pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension", Chest, 128, pp.619S~ (2005)
  45. Willers ED, "Serotonin transporter polymorphisms in familial and idiopathic pulmonary arterial hypertension", Am J Respir Crit Care Med, 173, pp.798~802 (2006)
  46. Amano S, "Polymorphism of the promoter region of prostacyclin synthase gene in chronic thromboembolic pulmonary hypertension", Respirology, 9, pp.184~189 (2004)
  47. Abraham WT, "Angiotensin-converting enzyme DD genotype in patients with primary pulmonary hype rtension: increased frequency and association with preserved haemodynamics", J Renin Angiotensin Aldosterone Syst, 4, pp.27~30 (2003)
  48. Aldashev AA, "Characterization of high-altitude pulmonary hypertension in the Kyrgyz: association with angiotensin- converting enzyme genotype", Am J Respir Crit Care Med, 166, pp.1396~1402 (2002)
  49. Shintani M, "A new nonsense mutation of SMAD8 associated with pulmonary arterial hypertension", J Med Genet, 46, pp.331~337 (2009)
  50. Schouten JP, "Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification", Nucleic Acids Res, 30, pp.e57~ (2002)

관련 논문AI추천

이 간행물의 다른 논문 (11건)